Global Radiotherapy Market 2018-2024: Technologies & Global Market – 2017-2024

Global Radiotherapy Market, By Type (Beam Radiotherapy (IGRT, IMRT, VMAT, Tomotherapy, 3D CRT, Proton Beam, Stereotactic), Brachytherapy (LDR, HDR), Systemic Radiotherapy), By Product Type (Cyberknife, Gammaknife, Linac, Proton Beam, Systemic Radiotherapy, Seeds, Afterloaders), By Indication (Prostate & Breast Cancer)), By Geography (North America, Europe, Asia Pacific, South America, Rest of the World)” – Industry Trends and Forecast to 2024

Click Here for Free Sample Report  https://tinyurl.com/ycxogft3

Global Radiotherapy Market
Global Radiotherapy Market

Global Radiotherapy Market is expected to reach USD 9.3 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 7.5% in the forecast period 2017 to 2024.

Radiotherapy Market Report provides comprehensive analysis of

Evolving market trends and dynamics

Changing supply and demand scenarios

Quantifying market opportunities through market sizing and market forecasting

Tracking current trends/opportunities/challenges

Competitive insights

Opportunity mapping in terms of technological breakthroughs

Key market segments and sub-segments

If you want to purchase this report kindly send the email @ sopan.gedam@databridgemarketresearch.com

Radiotherapy Market Overview:

Radiotherapy, ordinarily known as radiation treatment, is utilized for growth patients to cure malignancy by pulverizing the disease cells and diminishing the measure of tumors. X-beams, gamma beams, and charged particles are normally utilized radiations amid radiotherapy. As indicated by the National Cancer Institute, around half of malignancy patients get some kind of radiation treatment amid their treatment.

The market is driven by development in number of growth patients, increment in geriatric populace, ascend in selection of radiotherapy gadgets and systems, inferable from surge in number of mindfulness crusades about the advantages of radiotherapy, and innovative headways in radiotherapy gadgets. Be that as it may, lack of gifted work force and trouble in tumor representation limit the market development. Moreover, development openings in developing markets and increment sought after for malignancy treatment are relied upon to give various chances to advertise development amid the gauge time frame.

Market Key Drivers: Global Radiotherapy Market

Some of the major factors driving the market for radiotherapy market are increasing patient pool for cancer,increasing ageing population, increase in out-patient cancer facilities and increasing demand for better radiotherapy equipments and replacement of out dated products. One of the major factors for growth of these devices is owing to unmet needs of radiotherapy infrastructure in emerging and developed economies.

  • Regulatory scenario and the high cost of radiotherapy are the factors which may hinder the growth       of this market.
  • Many companies are increasingly focusing on radiotherapy devices in order to strengthen their product portfolios in the radiotherapy market.
  • Increment in patient mindfulness levels with respect to early infection diagnostics will drive the market in future.

Have Any Query? Inquire here @  https://tinyurl.com/y7uovrue

Global Radiotherapy Market Segmentation:

  • The global radiotherapy market is segmented on the basis of type, product type, indication, and geography. The global radiotherapy market is segmented into three types, namely beam radiotherapy, brachytherapy and systematic radiotherapy. In 2017, the beam radiotherapy segment is expected to dominate the market with a share around 75.0% and is expected to continue this trend till 2024.
  • Radiotherapy Market is segmented into beam radiotherapy, brachytherapy and systematic radiotherapy. The beam radiotherapy is segmented into IGRT, IMRT, VMAT, tomotherapy, stereotactic technology and 3D conformal technology. The brachytherapy is segmented into LDR and HDR.
  • On the basis of product type, the market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy softwares and systematic radiotherapy. External beam radiotherapy is segmented into LINAC, CyberKnife, proton therapy and Gamma Knife. The proton beam is segmented into cyclotron and synclotron. The internal beam is segmented into seeds and afterloaders. The radiotherapy softwares is segmented into treatment planning softwares, dosage planning softwares, patient positioning softwares and image guiding softwares.
  • On the basis of indication, the market is segmented into prostate cancer, breast cancer, lung cancer, spine cancer, liver cancer, brain cancer and others.

TABLE OF CONTENTS GLOBAL RADIOTHERAPY MARKET

1 INTRODUCTION

1.1. OVERVIEW OF GLOBAL RADIOTHERAPY MARKET

1.1.1. CURRENCY AND PRICING

1.1.2. LIMITATION

1.1.3. MARKETS COVERED

  1. MARKET SEGMENTATION

2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURCES

2.8. ASSUMPTIONS

  1. MARKET OVERVIEW

3.1. DRIVERS

3.1.1. GROWING PREVALENCE OF CANCER

3.1.2. RISING AGEING POPULATION

3.1.3. UNHEALTHY LIFESTYLE

3.1.4. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO

3.2.2. HIGH COST OF RADIOTHERAPY

3.3. OPPORTUNITIES

3.3.1. GROWING MEDICAL TOURISM IN ASIA

3.3.2. EMERGING MARKET

3.4. CHALLENGES

3.4.1. SIDE-EFFECTS OF RADIOTHERAPY

3.4.2. REQUIREMENT OF TRAINED STAFF

  1. EXECUTIVE SUMMARY
  2. PREMIUM INSIGHTS
  3. GLOBAL RADIOTHERAPY MARKET, BY THERAPY TYPE

6.1. OVERVIEW

6.2. BEAM RADIOTHERAPY, BY THERAPY TYPE

6.3. BRACHYTHERAPY, BY THERAPY TYPE

  1. GLOBAL RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.1. OVERVIEW

7.2. GLOBAL EXTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.3. GLOBAL INTERNAL BEAM RADIOTHERAPY MARKET, BY PRODUCT TYPE

7.4. GLOBAL RADIOTHERAPY SOFTWARES MARKET, BY PRODUCT TYPE

  1. GLOBAL RADIOTHERAPY MARKET, BY INDICATION

8.1. OVERVIEW

  1. GLOBAL RADIOTHERAPY MARKET, BY GEOGRAPHY

9.1. OVERVIEW

9.2. NORTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.2.1. U.S. RADIOTHERAPY MARKET

9.2.2. CANADA RADIOTHERAPY MARKET

9.2.3. MEXICO RADIOTHERAPY MARKET

9.3. EUROPE RADIOTHERAPY MARKET

9.3.1. GERMANY RADIOTHERAPY MARKET

9.3.2. FRANCE RADIOTHERAPY MARKET

9.3.3. U.K. RADIOTHERAPY MARKET

9.3.4. SWITZERLAND RADIOTHERAPY MARKET

9.3.5. ITALY RADIOTHERAPY MARKET

9.3.6. RUSSIA RADIOTHERAPY MARKET

9.3.7. NETHERLANDS RADIOTHERAPY MARKET

9.3.8. SPAIN RADIOTHERAPY MARKET

9.3.9. BELGIUM RADIOTHERAPY MARKET

9.3.10. TURKEY RADIOTHERAPY MARKET

9.4. APAC RADIOTHERAPY MARKET SNAPSHOT: 2016

9.4.1. JAPAN RADIOTHERAPY MARKET

9.4.2. CHINA RADIOTHERAPY MARKET

9.4.3. INDIA RADIOTHERAPY MARKET

9.4.4. SOUTH KOREA RADIOTHERAPY MARKET

9.4.5. AUSTRALIA RADIOTHERAPY MARKET

9.4.6. THAILAND RADIOTHERAPY MARKET

9.4.7. MALAYSIA RADIOTHERAPY MARKET

9.4.8. INDONESIA RADIOTHERAPY MARKET

9.4.9. SINGAPORERADIOTHERAPY MARKET

9.4.10. PHILIPPINES RADIOTHERAPY MARKET

9.5. SOUTH AMERICA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.5.1. BRAZIL RADIOTHERAPY MARKET

9.6. MEA RADIOTHERAPY MARKET SNAPSHOT: 2016

9.6.1. SAUDI ARABIA RADIOTHERAPY MARKET

  1. GLOBAL RADIOTHERAPY MARKET, COMPANY SHARE

10.1. COMPANY SHARE ANALYSIS: GLOBAL

10.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

10.3. COMPANY SHARE ANALYSIS: EUROPE

10.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

  1. COMPANY PROFILES

11.1. VARIAN MEDICAL SYSTEMS, INC.

11.1.1. COMPANY OVERVIEW

11.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.1.3. DRIVERS EXPLAINED

11.1.3.1. DIVERSE PRODUCT PORTFOLIO:

11.1.3.2. STRONG RESEARCH AND DEVELOPMENT CAPABILITIES:

11.1.4. WEAKNESSES EXPLAINED

11.1.4.1. DEPENDENCE ON LIMITED NUMBER OF SUPPLIERS:

11.1.5. OPPURTUNITIES EXPLAINED

11.1.5.1. VARIAN COULD EXPAND ITS POSITION WITH IMAGING COMPONENTS BUSINESS’ SPIN-OFF:

11.1.5.2. ACQUISITIONS LIKELY TO ENHANCE VARIAN’S ONCOLOGY AND IMAGING BUSINESSES:

11.1.5.3. EXPANSION IN OPERATIONS IN THE U.S.:

11.1.5.4. INCREASING INCIDENCE OF CANCER TO DRIVE GLOBAL RADIATION THERAPY EQUIPMENT MARKET:

11.1.6. THREATS EXPLAINED

11.1.6.1. INTENSE COMPETITION COULD AFFECT VARIAN’S MARKET SHARE AND RESULTS OF OPERATION:

11.1.6.2. INCREASING MEDICAL COSTS IN CANCER TREATMENT AND CARE: 259

11.1.7. REVENUE ANALYSIS

11.1.8. PRODUCT PORTFOLIO

11.1.9. RECENT DEVELOPMENTS

11.1.10. DATA BRIDGE ANALYSIS

11.2. ELEKTA AB

11.2.1. COMPANY OVERVIEW

11.2.2. REVENUE ANALYSIS

11.2.3. PRODUCT PORTFOLIO

11.2.4. RECENT DEVELOPMENTS

11.2.5. DATA BRIDGE ANALYSIS

11.3. NANOBIOTIX

11.3.1. COMPANY OVERVIEW

11.3.2. REVENUE ANALYSIS

11.3.3. PRODUCT PORTFOLIO

11.3.4. RECENT DEVELOPMENTS

11.3.5. DATA BRIDGE ANALYSIS

11.4. ACCURAY, INC.

11.4.1. COMPANY OVERVIEW

11.4.2. REVENUE ANALYSIS

11.4.3. PRODUCT PORTFOLIO

11.4.4. RECENT DEVELOPMENTS

11.5. BRAINLAB AG

11.5.1. COMPANY OVERVIEW

11.5.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.5.3. DRIVERS EXPLAINED

11.5.3.1. STRONG PARTNER NETWORK:

11.5.3.2. ESTABLISHED PRESENCE IN MARKETS:

11.5.4. WEAKNESSES EXPLAINED

11.5.4.1. PRODUCT SAFETY CONCERNS:

11.5.5. OPPURTUNITIES EXPLAINED

11.5.5.1. STRATEGIC INITIATIVES:

11.5.6. THREATS EXPLAINED

11.5.6.1. RAPID TECHNOLOGICAL CHANGES:

11.5.6.2. STRINGENT GOVERNMENT REGULATIONS:

11.5.7. REVENUE ANALYSIS

11.5.8. PRODUCT PORTFOLIO

11.5.9. RECENT DEVELOPMENTS

11.6. ION BEAM APPLICATIONS SA

11.6.1. COMPANY OVERVIEW

11.6.2. REVENUE ANALYSIS

11.6.3. PRODUCT PORTFOLIO

11.6.4. RECENT DEVELOPMENTS

11.7. MEVION MEDICAL SYSTEMS, INC.

11.7.1. COMPANY OVERVIEW

11.7.2. REVENUE ANALYSIS

11.7.3. PRODUCT PORTFOLIO

11.7.4. RECENT DEVELOPMENTS

11.8. ISORAY MEDICAL, INC.

11.8.1. COMPANY OVERVIEW

11.8.2. REVENUE ANALYSIS

11.8.3. PRODUCT PORTFOLIO

11.8.4. RECENT DEVELOPMENTS

11.9. NORDION (CANADA) INC.

11.9.1. COMPANY OVERVIEW

11.9.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

11.9.3. DRIVERS EXPLAINED

11.9.3.1. ESTABLISHED PRESENCE IN GAMMA IRRADIATION INDUSTRY:

11.9.4. WEAKNESSES EXPLAINED

11.9.4.1. RADIATION EXPOSURE CLAIMS AND OTHER DISPUTES:

11.9.5. OPPURTUNITIES EXPLAINED

11.9.5.1. STRATEGIC INITIATIVES:

11.9.6. THREATS EXPLAINED

11.9.6.1. RAPID TECHNOLOGICAL CHANGES:

11.9.6.2. STRINGENT GOVERNMENT REGULATIONS:

11.9.6.3. STIFF COMPETITION:

11.9.7. REVENUE ANALYSIS

11.9.8. PRODUCT PORTFOLIO

11.9.9. RECENT DEVELOPMENTS

11.10. RAYSEARCH LABORATORIES AB

11.10.1. COMPANY OVERVIEW

11.10.2. REVENUE ANALYSIS

11.10.3. PRODUCT PORTFOLIO

11.10.4. RECENT DEVELOPMENTS

11.11. PRECISIS AG

11.11.1. COMPANY OVERVIEW

11.11.2. REVENUE ANALYSIS

11.11.3. PRODUCT PORTFOLIO

11.11.4. RECENT DEVELOPMENTS

  1. RELATED REPORTS

Read more about the Global Radiotherapy Market@  https://tinyurl.com/yccno43l

Related Report

North America Digital Health Monitoring Market – Industry Trends and Forecast to 2024

North America Digital Health Monitoring Market By Product Type Devices (Blood Pressure Monitors, Blood Glucose Monitors, ECG, Oximeters, Peak Flow Monitors, Multi Parameter Monitors, Sleep Neap Monitors, Neurological Monitors, Others), Software (Healthcare Apps, Chronic Disease Apps, Personal Health Apps, Others), Services (Remote Monitoring, Consultancy Services, Treatment Services, Fitness and Wellness Services, Others), By Country (U.S., Canada, Mexico) –  Industry Trends and Forecast to 2024.

Report Access: http://databridgemarketresearch.com/reports/north-america-digital-health-monitoring-devices-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com